3rd Quarter - Report — INDIVIOR INC for INDIVIOR INC (2024)

Firm

INDIVIOR INC

Client

INDIVIOR INC

Income

—

Expenses

$230,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

SUPPORT for Patients and Communities Reauthorization Act (HR 4531 / S 2433, S 3106, S 3393); HEAL Act (HR 4007 / S 2809); PAHPA Act (HR 4421 / S 2333); Reentry Act (HR 2400 / S 1165); Due Process Continuity of Care Act (HR 3074 / S 971); FY25 appropriations for Labor-HHS-Education, Military Construction & Veterans Affairs, and Commerce-Justice-Science; DEA rulemaking on telemedicine prescribing of controlled substances (RIN #1117-AB40); CMS Physician Fee Schedule CY25 Proposed Rule (RIN #0938-AV33)

Lobbyist	Covered position, as disclosed
FRANK J. PURCELL	—

Contacted: Office of Natl Drug Control Policy (NDCP); SENATE; Centers For Medicare and Medicaid Services (CMS); Centers For Disease Control & Prevention (CDC); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES

Bills named: H.R. 4007 (118th), H.R. 2400 (118th), H.R. 3074 (118th), H.R. 4421 (118th), H.R. 4531 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.